MedCap AB (publ) is a renowned company that holds a strong set of values and corporate philosophy. The company is dedicated to excellence, integrity, and continuous growth. MedCap AB (publ) prioritizes the well-being of its clients and focuses on delivering high-quality services and products. Emphasizing transparency and professionalism, MedCap AB (publ) maintains a customer-centric approach, ensuring utmost trust and satisfaction. With a commitment to innovation and adaptability, MedCap AB (publ) aims to stay ahead in the ever-evolving stock market landscape, offering its clients unmatched opportunities and value. Trust MedCap AB (publ) for a reliable and principled partner in your investment journey.

MedCap AB (publ) is primarily present in Sweden.

MedCap AB (publ) has achieved several significant milestones in its journey. One of the key milestones for the company was the successful completion of its initial public offering (IPO), which provided a platform for increased visibility and access to capital. Additionally, MedCap AB (publ) has made major strides in expanding its portfolio through strategic acquisitions and partnerships, strengthening its position in the market. The company's commitment to continuous innovation and research has also led to the development of groundbreaking products and therapies, further solidifying its reputation as a leader in the healthcare industry. These achievements underscore MedCap AB (publ)'s dedication to growth and positioning itself as a frontrunner in the market.

MedCap AB (publ), a leading healthcare investment company, has a rich history and background. Established in 1999, MedCap focuses on investing in and developing innovative companies within the healthcare sector. With a mission to drive growth and create value, MedCap has become well-known for its expertise and long-term approach. The company has an impressive track record of successful investments and collaborations, contributing to advancements in medical technology, pharmaceuticals, and healthcare services. MedCap AB (publ) continues to foster strategic partnerships and actively seeks opportunities to support promising healthcare ventures, ensuring its continued growth and impact in the industry.

The main competitors of MedCap AB (publ) in the market include other companies operating in the healthcare and pharmaceutical industries. Some prominent competitors are ABC Company, XYZ Pharmaceuticals, and DEF Healthcare. MedCap AB (publ) faces stiff competition in terms of market share, product development, and innovation. However, it has managed to establish a strong presence and competitive edge through its unique product offerings, strategic partnerships, and focus on customer satisfaction.

MedCap AB (publ) is primarily active in the healthcare and pharmaceutical industries.

MedCap AB (publ) operates as a healthcare-focused investment company in Sweden. The company's business model revolves around identifying and investing in innovative healthcare companies with growth potential. MedCap aims to create long-term value by providing financial resources, strategic guidance, and operational support to the companies it invests in. By leveraging its expertise and network within the healthcare industry, MedCap aims to contribute to the development of the healthcare sector and generate profitable returns for its shareholders. MedCap AB (publ) focuses on investments in both listed and unlisted healthcare companies across various therapeutic areas and market segments.

The MedCap AB (publ) P/E ratio is 37.02.

The MedCap AB (publ) P/S ratio is 6.8.

The AlleAktien quality score for MedCap AB (publ) is 8/10.

The expected MedCap AB (publ) revenue is 1.07 B SEK.

The expected MedCap AB (publ) profit is 196.24 M SEK.

The company MedCap AB (publ) is a Swedish company specialized in investments in the healthcare sector. MedCap's business model is based on identifying and financing promising developments and companies in the healthcare sector to support their further growth and expansion of their services. MedCap is divided into various divisions. The Consumer Goods and Devices division is a leader in the Scandinavian region, offering innovative and high-quality products for the healthcare market. Their products include consumables for home care, disposable products for hospitals, and surgical instruments. The company works closely with reputable medical facilities to ensure their products meet customer needs. Another division of MedCap is the Life Science business field. Here, the company participates in research projects relevant to the development of new drugs and therapies. MedCap collaborates closely with emerging biotech companies and start-ups, providing financial support for development projects. The company aims to be a pioneer in the growing and innovative healthcare sector through its investments in Life Science. Another important pillar of MedCap is the healthcare services sector. In this area, the company offers extensive services to healthcare sector companies, including outsourcing of pharmaceutical and laboratory services, consulting for product launches, training for medical professionals, and the provision of digital health solutions. For example, in recent years, the company has strengthened its position as a leader in digital medicine in Scandinavia through the establishment of telemedicine companies. Overall, MedCap focuses on diversification and innovative growth in all parts of the healthcare sector. The company aims to expand its position as a leading player and pioneer in the industry in the future and to add more high-quality and effective products and services to its portfolio. In summary, MedCap's business model is based on innovative products and services in the healthcare sector. Through targeted investments in research and development, as well as collaborations with established partners and promising start-ups, the Swedish company has become a pioneer in the industry in recent years. With its diverse portfolio and a strategic focus on the needs of the healthcare sector, MedCap is on track to continue its growth trajectory in the future.

MedCap AB (publ) pays a dividend of 0 SEK distributed over payouts per year.

The dividend cannot currently be calculated for MedCap AB (publ) or the company does not pay out a dividend.

The ISIN of MedCap AB (publ) is SE0009160872.

The WKN of MedCap AB (publ) is A2ASQ7.

The ticker of MedCap AB (publ) is MCAP.ST.

Over the past 12 months, MedCap AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedCap AB (publ) is expected to pay a dividend of 0 SEK.

The current dividend yield of MedCap AB (publ) is .

MedCap AB (publ) pays a quarterly dividend. This is distributed in the months of .

MedCap AB (publ) paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

MedCap AB (publ) is assigned to the 'Health' sector.

To receive the latest dividend of MedCap AB (publ) from 9/12/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

The last dividend was paid out on 9/12/2024.

In the year 2023, MedCap AB (publ) distributed 0 SEK as dividends.

The dividends of MedCap AB (publ) are distributed in SEK.